United States Patent US6113940:
Cannabinoid patch and method for cannabis transdermal delivery.

We  found this patent application in the U.S for a cannabis patch similar to the nicotine patch which has been commercially available for years. Several companies (and even the U.S government – see our previous article “U.S Government Patents Cannabis“) have recently started to take notice of the medicinal properties of cannabis and have started a rush to patent any possible application of this wonderful natural herb. Part of this trend could be linked to the legalization movement which has successfully highlighted several medical advantages to cannabis over traditional pharmaceuticals, particularly the lack of significant negative side-effects when treating serious illness.

Here are the links to both the Patent outline and the Application in .pdf form

This just shows how much of a fraud the whole prohabition of cannabis is. The US Government’s statement that there is “no current use for medical treatment in the United States” is a lie and they know it. The most disturbing about it is that United States patent No. 6,630,507 has been filled in 2001 already and that you have to hear about it through a weblog.

Why isn’t this big news? Why is there no reporter that asks these kind of questions? If the media doesn’t address these kind of issues, what good are they?

Below the abstract from the patent filed by the US government “as represented by the Department of Health and Human Services”:

“Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH.sub.3, and COCH.sub.3.”

Special thanks to spryeye and evanravitz for bringing this information to our attention.

Posted in Cannabis News, Cannabis Research